Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
- Cancer
- Head and Neck Cancer
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- M.D. Anderson Cancer Center
- Enrolment target
- 40
- Started
- 13 January 2025
- Main results due
- 1 August 2028
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: In order to be eligible to participate in the intervention group of this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Aged 18 or greater * Patient scheduled to undergo facial nerve transfer * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study In order to be eligible to participate in the non-intervention historical control group of this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Aged 18 or greater * Previous facial surgery severing a facial nerve without graft or other form of dynamic facial nerve reconstruction within the last 20 years Exclusion Criteria: Patients known to be pregnant
What this study is about
In the sponsor’s own words, from the registry.
The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.
Study sites(1)
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06667427. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me